VNDA
Vanda Pharmaceuticals Inc
Price:  
5.02 
USD
Volume:  
469,017.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VNDA WACC - Weighted Average Cost of Capital

The WACC of Vanda Pharmaceuticals Inc (VNDA) is 7.1%.

The Cost of Equity of Vanda Pharmaceuticals Inc (VNDA) is 10.50%.
The Cost of Debt of Vanda Pharmaceuticals Inc (VNDA) is 5.00%.

Range Selected
Cost of equity 9.00% - 12.00% 10.50%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.3% - 7.8% 7.1%
WACC

VNDA WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.11 1.27
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.00% 12.00%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.3% 7.8%
Selected WACC 7.1%